[Ganglionnar Hodgkin lymphoma associated to a Castleman's disease].
Chelly
Ines
I
Bellil
Selma
S
Nfoussi
Haifa
H
Mekni
Amina
A
Tangour
Monia
M
Kilani
Houda
H
Haouet
Slim
S
Kchir
Nidhammedie
N
Zitouna
Moncef
M
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D005871:Castleman Disease / Q000150:complications* / Q000175:diagnosis; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D016539:Reed-Sternberg Cells; D012074:Remission Induction; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D018931:Antineoplastic Agents, Hormonal; D005938:Glucocorticoids; D011241:Prednisone